SCHEMBL21264786

SCHEMBL21264786

c1cc(-n2c3ccccc3n3c4ccccc4cc23)cc(-n2c3ccccc3n3c4ccccc4cc23)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.39
TSHR P16473 1/20 0.39
PLA2G10 O15496 7/20 0.38
KMT2A Q03164 2/20 0.33
GAA P10253 1/20 0.33
PKM P14618 1/20 0.33
CASP1 P29466 1/20 0.33
GALK1 P51570 1/20 0.33
BLM P54132 1/20 0.33
CASP7 P55210 1/20 0.33
HSD17B10 Q99714 1/20 0.33
SAE1 Q9UBE0 1/20 0.33
UBA2 Q9UBT2 1/20 0.33
L3MBTL1 Q9Y468 2/20 0.33
NOTUM Q6P988 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
PBRM1 Q86U86 1/20 0.33
KDM4E B2RXH2 1/20 0.32
ATM Q13315 1/20 0.32
LMNA P02545 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21264787 0.93 ALDH1A1 (0.35) ALDH1A1TSHRPLA2G10L3MBTL1SMN1; SMN2
SCHEMBL21264464 0.92 KDM4E (0.47) ALDH1A1TSHRPLA2G10KMT2AGAA
SCHEMBL23075524 0.91 ALDH1A1 (0.47) ALDH1A1TSHRPLA2G10KMT2AGAA
SCHEMBL24171621 0.89 ALDH1A1 (0.39) ALDH1A1TSHRPLA2G10KMT2APKM
SCHEMBL21264472 0.87 KDM4E (0.42) ALDH1A1TSHRPLA2G10KMT2AGAA
SCHEMBL21264594 0.85 KDM4E (0.49) ALDH1A1TSHRPLA2G10KMT2AGAA
SCHEMBL20929428 0.85 MAPK1 (0.35) ALDH1A1TSHRPLA2G10KMT2ASMN1; SMN2
SCHEMBL21264465 0.85 MAPK1 (0.35) ALDH1A1TSHRPLA2G10KMT2ASMN1; SMN2
SCHEMBL21264776 0.85 ALDH1A1 (0.38) ALDH1A1TSHRPLA2G10GAAKDM4E
SCHEMBL21264739 0.84 KDM4E (0.47) ALDH1A1TSHRPLA2G10KMT2AGAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230147279-A1 HETEROCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES UDC IRELAND LIMITED (IE) 2023-05-11 US disclosed
WO-2021185829-A1 HETEROCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES MERCK PATENT GMBH (DE) 2021-09-23 WO disclosed
US-20190252623-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION 2019-08-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190252623-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES ZYX, NSD3, NES ALDH1A1 3144/4885TSHR 3428/4885PLA2G10 3999/4885
US-20230147279-A1 HETEROCYCLIC COMPOUNDS FOR ORGANIC ELECTROLUMINESCENT DEVICES DDT, VDAC2, KCNC1 ALDH1A1 649/4885TSHR 4593/4885PLA2G10 4537/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.